Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Reitsamer

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Breast Cancer Research and Treatment|April 9, 2009
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and peripheryEvangelia-Ourania Fourkala, Cornelia Hauser-Kronberger, Sophia Apostolidou, et al.
Genes|December 1, 2020
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast CancerBarbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Clinical Epigenetics|March 11, 2016
Hsa-miR-375 is a predictor of local control in early stage breast cancerFranz Zehentmayr, Cornelia Hauser-Kronberger, Barbara Zellinger, et al.
Cancers|February 13, 2025
Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM ApproachesSara Vockner, Matthias Mattke, Ivan M Messner, et al.
Breast Care (Basel, Switzerland)|March 31, 2022
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)Theresa Westphal, Simon P Gampenrieder, Gabriel Rinnerthaler, et al.
Cancer Science|February 17, 2010
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumorsRegina Berger, Heidi Fiegl, Georg Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Wiener Klinische Wochenschrift|April 3, 2023
Axillary lymph node status and invasive lobular breast cancer : Analysis of the Clinical Tumor Register of the AGO AustriaSabine Danzinger, Karin Pöckl, Gerit Kronawetter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysisGerd Fastner, Felix Sedlmayer, Florian Merz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2020
Central Review of Radiation Therapy Planning Among Patients with Breast-Conserving Surgery: Results from a Quality Assurance Process Integrated into the INSEMA TrialGuido Hildebrandt, Angrit Stachs, Bernd Gerber, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Breast Cancer Research and Treatment|April 9, 2009
DNA methylation of polycomb group target genes in cores taken from breast cancer centre and peripheryEvangelia-Ourania Fourkala, Cornelia Hauser-Kronberger, Sophia Apostolidou, et al.
Genes|December 1, 2020
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast CancerBarbara Zellinger, Ulrich Bodenhofer, Immanuela A Engländer, et al.
Clinical Epigenetics|March 11, 2016
Hsa-miR-375 is a predictor of local control in early stage breast cancerFranz Zehentmayr, Cornelia Hauser-Kronberger, Barbara Zellinger, et al.
Cancers|February 13, 2025
Cone-Beam CT Segmentation for Intraoperative Electron Radiotherapy Based on U-Net Variants with Transformer and Extended LSTM ApproachesSara Vockner, Matthias Mattke, Ivan M Messner, et al.
Breast Care (Basel, Switzerland)|March 31, 2022
Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)Theresa Westphal, Simon P Gampenrieder, Gabriel Rinnerthaler, et al.
Cancer Science|February 17, 2010
Toll-like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumorsRegina Berger, Heidi Fiegl, Georg Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancerHeidi Fiegl, Allison Jones, Cornelia Hauser-Kronberger, et al.
Wiener Klinische Wochenschrift|April 3, 2023
Axillary lymph node status and invasive lobular breast cancer : Analysis of the Clinical Tumor Register of the AGO AustriaSabine Danzinger, Karin Pöckl, Gerit Kronawetter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysisGerd Fastner, Felix Sedlmayer, Florian Merz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 22, 2020
Central Review of Radiation Therapy Planning Among Patients with Breast-Conserving Surgery: Results from a Quality Assurance Process Integrated into the INSEMA TrialGuido Hildebrandt, Angrit Stachs, Bernd Gerber, et al.
Pageof 7